Autoantibody Profile in Systemic Sclerosis

Show other versions (1)

Systemic sclerosis is a generalized disorder of connective tissue clinically characterized by thickening and fibrosis of the skin and by distinctive forms of involvement of internal organs. One of the hallmarks of systemic sclerosis is the presence of serum autoantibodies against a variety of nuclea...

Full description

Bibliographic Details
Main Authors:	Fatemeh Behmanesh, Reza Amin, Mohammad Khajedaluee, Marvin J Fritzler
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2010-02-01
Series:	Acta Medica Iranica
Subjects:	Autoantibodies scleroderma systemic nuclear antigens
Online Access:	https://acta.tums.ac.ir/index.php/acta/article/view/3640

Similar Items

Autoantibody Profile in Systemic Sclerosis
by: Marvin J Fritzler, et al.
Published: (2010-02-01)

Autoantibodies in systemic sclerosis: Unanswered questions
by: CRISTIANE eKAYSER, et al.
Published: (2015-04-01)

Disease-related autoantibody profile in patients with systemic sclerosis
by: Christos Liaskos, et al.
Published: (2017-10-01)

Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis
by: Carine Moezinia, et al.
Published: (2023-10-01)

Ophthalmologic profile of patients with systemic sclerosis
by: Sandeep Choudhary, et al.
Published: (2025-04-01)

Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis
by: Muruganandam M, et al.
Published: (2023-10-01)

Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival
by: Abdulla Watad, et al.
Published: (2019-06-01)

Advanced Autoantibody Testing in Systemic Sclerosis
by: Kholoud Almaabdi, et al.
Published: (2023-02-01)

Extended autoantibody panel in Turkish patients with early‐stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes
by: Duygu Temiz Karadağ, et al.
Published: (2023-12-01)

Dysregulated B cell function and disease pathogenesis in systemic sclerosis
by: Claire F. Beesley, et al.
Published: (2023-01-01)

Associations of autoantibodies and clinical profile of the patients with systemic sclerosis
by: Shahin Mahmud, et al.
Published: (2022-09-01)

Auto-anticorpos na Esclerose Sistêmica (ES) Autoantibody in the Systemic Sclerosis (SS)
by: Luís Eduardo Coelho Andrade, et al.
Published: (2004-06-01)

Profile of autoantibodies in systemic sclerosis
by: M. N. Starovoitova, et al.
Published: (2016-10-01)

Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players
by: Aurélien Chepy, et al.
Published: (2025-06-01)

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
by: Jakob Höppner, et al.
Published: (2023-01-01)

Circulation autoantibodies against C-terminus of NuMA in patients with Behçet’s disease
by: Muhammad Hussain, et al.
Published: (2020-04-01)

AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE
by: L. P. Ananyeva, et al.
Published: (2016-03-01)

Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests
by: Wynand Alkema, et al.
Published: (2021-04-01)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
by: Bruno Stuhlmüller, et al.
Published: (2019-05-01)

The presence of autoantibodies is associated with improved overall survival in lung cancer patients
by: Keying Jing, et al.
Published: (2023-09-01)

Deciphering the Autoantibody Response to the OJ Antigenic Complex
by: Marvin J. Fritzler, et al.
Published: (2023-01-01)

The Utilization of Autoantibodies in Approaches to Precision Health
by: Marvin J. Fritzler, et al.
Published: (2018-11-01)

Emerging technologies in autoantibody testing for rheumatic diseases
by: Nancy J. Olsen, et al.
Published: (2017-07-01)

Corrigendum: The presence of autoantibodies is associated with improved overall survival in lung cancer patients
by: Keying Jing, et al.
Published: (2023-12-01)

ASSESSMENT OF THE PATIENT’S ORGANS AND SYSTEMS BASED ON CHANGES IN THE CONTENT OF AUTOANTIBODY MARKERS
by: Kh. Kh. Gantseva, et al.
Published: (2017-01-01)

Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application
by: Jan Damoiseaux, et al.
Published: (2022-01-01)

Cancer Is Associated with the Emergence of Placenta-Reactive Autoantibodies
by: Sara Khorami Sarvestani, et al.
Published: (2023-01-01)

A rare cutaneous manifestation of systemic sclerosis
by: Joelle Sleiman, et al.
Published: (2024-10-01)

Autoantibodies research progress /
by: Dubois, Quentin P.
Published: (2008)

Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review
by: Mahsa Ranjbar, et al.
Published: (2024-08-01)

Association between Localized Scleroderma Cutaneous Assessment Tool and clinicopathologic characteristics in patients with morphea
by: Yıldız Gürsel Ürün, et al.
Published: (2022-09-01)

Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients
by: Kamonwan Mulalin, et al.
Published: (2024-05-01)

Profile of systemic sclerosis and associated renal involvement
by: Neehar Shanavas, et al.
Published: (2015-01-01)

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
by: Elvis Hysa, et al.
Published: (2023-01-01)

Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
by: Elopy N. Sibanda, et al.
Published: (2021-11-01)

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
by: Hanna Graßhoff, et al.
Published: (2022-09-01)

Autoantibody Profile and Lung HRCT Scan in Systemic Sclerosis with Restrictive Lung Disease
by: Winda Agnestia Maranna Saragih, et al.
Published: (2023-03-01)

High-throughput autoantibody profiling of different stages of Schistosomiasis japonica
by: Xiaorong Zhou, et al.
Published: (2023-12-01)

Presence of autoantibodies and epidemiological characteristics of systemic sclerosis patients in western Paraná
by: Alana Rubia Balbinot, et al.
Published: (2022-10-01)

Identification of nuclear valosin-containing-protein-like as a target of anti-nuclear autoantibodies in systemic sclerosis
by: Zitao Zeng, et al.
Published: (2025-01-01)